Senate Plans Legislation to Prepare for Next Pandemic Like COVID-19
WASHINGTON — The U.S. Senate tried Tuesday to respond to warnings from infectious disease experts that coronavirus is only an example of other pandemics that are coming soon.
The World Health Organization has warned that a global population topping 7.8 billion plus global warming are creating a breeding ground for the kind of viruses that can devastate people and economies.
The Senate Health, Education, Labor and Pensions Committee wants to use coronavirus as an incubator for ideas to prepare for the next pandemic.
“COVID 19 has exposed some gaps,” Sen. Lamar Alexander, R-Tenn., said during a hearing Tuesday about the nation’s preparations for the pandemic.
He gave a glimpse of a bill the committee he chairs is putting together for introduction in the Senate soon.
It would provide funding to accelerate research and development on vaccines, expand a network for early detection of outbreaks, stockpile medicines and personal protective equipment and assist states in responding to diseases.
Alexander said Congress should “pass legislation this year to be prepared for the next pandemic that will surely come.”
Many provisions of the bill he is overseeing are derived from a plan proposed 15 years ago by former Senate Majority Leader Bill Frist, who was a witness at the hearing Tuesday.
Frist called his plan the “Manhattan Project of the 21st Century,” which is taken from the name of the World War II project to develop a nuclear bomb.
“Most of what I recommended in 2005 remains undone,” Frist told the Senate committee.
He suggested that new disease prevention and response programs be funded from the U.S. defense budget. This year’s fiscal year defense budget is $721.5 billion.
“Health security is national security,” Frist said.
He also recommended more public-private partnerships to manufacture the medical equipment needed for pandemic responses.
Julie L. Gerberding, chief patient officer for pharmaceutical giant Merck & Co., said the federal government must be willing to pursue research and development for new disease-fighting technologies even if there is no certainty of success.
“If we aim for efficiency, we’re going to be slow and miss the boat,” Gerberding said.
She mentioned the federal government’s Biomedical Advanced Research and Development Authority (BARDA) as an organization that could take the lead in research and development.
On Tuesday, BARDA announced the latest of several public-private ventures to develop a rapid COVID-19 test. The technology from MBio Diagnostics uses blood flowing through a cartridge to measure antibodies that indicate the presence of disease in as little as five minutes.
BARDA also is working to develop vaccines, medicines and infection control equipment.
The hearing took place as the number of reported coronavirus cases hit record levels in 23 states this week. Nationwide, 2.3 million cases have been reported with more than 120,000 deaths.
One of the states hardest hit is Texas, where disease experts this week accused the federal government of a slow response to the outbreak.
“What’s next,” asked Gerald Parker, director of the pandemic and biosecurity program at Texas A&M’s Bush School of Public Service, during a televised interview. “We must prevent this from happening again. COVID-19 is not a 100 year event like some people are saying.”
At a separate U.S. House hearing Tuesday, Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said states are opening too soon to avoid a resurgence of the disease.
Although deaths from the virus have been dropping in the past few days, the number of infections is going up.
“Deaths always lag considerably behind cases,” he said.
In The News
WASHINGTON — Dr. Anthony Fauci says if a coronavirus vaccine is available, regardless of which one, take it. The top U.S. infectious disease expert told NBC on Thursday a third vaccine becoming available “is nothing but good news” and would help control of the pandemic. U.S.... Read More
WASHINGTON — President Joe Biden said during a virtual meeting with essential workers on Wednesday that the administration plans to distribute millions of cloth face masks beginning early next month. According to a statement from the White House, the reusable, American-made masks will be available beginning in March... Read More
WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration's scientists confirmed that overall the... Read More
WASHINGTON — The House Budget Committee approved reconciliations to President Joe Biden’s proposed $1.9 trillion novel coronavirus relief legislation Monday, setting in motion the bill’s final vote in the full House of Representatives expected to follow this week. If enacted, the legislation would provide $1,400 economic... Read More
WASHINGTON (AP) — Democratic leaders have a potent dynamic on their side as Congress preps for its first votes on the party's $1.9 trillion COVID-19 relief bill: Would any Democrat dare cast the vote that scuttles new President Joe Biden's leadoff initiative?Democrats' wafer-thin 10-vote House majority... Read More
The U.S. stood Sunday at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus.A year into the pandemic, the running total of lives lost was about 498,000 — roughly the population of Kansas City, Missouri, and just shy of the size of Atlanta.... Read More